Peripheral vein in children.
Conditions
Interventions
Intervention 1: Intervention group: Intranasal injection of Midazolam 0.2 mg / kg, 20 minutes before the procedure with the MAD. Intervention 2: Intervention group: Intranasal injection of Ketamine 5
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 10 Years
Inclusion criteria
Inclusion criteria: Age over one year Parental consent for the child to participate in the project
Exclusion criteria
Exclusion criteria: Immunodeficiency Down syndrome Chronic heart and pulmonary disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Saturation of oxygen. Timepoint: 10 minutes after the procedure. Method of measurement: Pulse Oximetry.;The number of pulses. Timepoint: 10 minutes after the procedure. Method of measurement: Based on patient records.;Breath rate. Timepoint: 10 minutes after the procedure. Method of measurement: Based on patient records.;The severity of pain after the procedure. Timepoint: 10 minutes after the procedure. Method of measurement: Observational Scale of Behavioral Distress-Revised.;The amount of sedation. Timepoint: 10 minutes after the procedure. Method of measurement: Observational Scale of Behavioral Distress-Revised. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShabahang Jafarnejad
Iran University of Medical Sciences
Outcome results
None listed